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Abstract 
Phosphatidylethanolamine N-methyltransferase (Pemt) catalyzes the methylation of 
phosphatidylethanolamine (PE) to phosphatidylcholine (PC) mainly in the liver. Under 
an obese state, the upregulation of Pemt induces endoplasmic reticulum (ER) stress by 
increasing the PC/PE ratio in the liver. We targeted the Pemt gene in mice to explore the 
therapeutic impact of Pemt on the progression of diabetic nephropathy and diabetes, 
which was induced by the injection of streptozotocin (STZ). Although the blood glucose 
levels were similar in STZ-induced diabetic Pemt+/+ and Pemt-/-mice, the glomerular 
hypertrophy and albuminuria in Pemt-/- mice were significantly reduced. Pemt 
deficiency reduced the intraglomerular F4/80-positive macrophages, hydroethidine 
fluorescence, tubulointerstitial fibrosis and tubular atrophy. The expression of 
glucose-regulated protein-78 (GRP78) was enriched in the renal tubular cells in 
STZ-induced diabetic mice, and this was ameliorated by Pemt deficiency. In mProx24 
renal proximal tubular cells, the treatment with ER-stress inducers, tunicamycin and 
thapsigargin, increased the expression of GRP78, which was reduced by transfection of 
a shRNA lentivirus for Pemt (shRNA-Pemt). The number of apoptotic cells in the renal 
tubules was significantly reduced in Pemt-/- diabetic mice, and shRNA-Pemt 
upregulated the phosphorylation of Akt and decreased the cleavage of caspase 3 and 7 in 
mProx24 cells. Taken together, these findings indicate that the inhibition of Pemt 
activity ameliorates the ER stress associated with diabetic nephropathy in a model of 
type 1 diabetes and corrects the functions of the three major pathways downstream of 
ER stress, i.e. oxidative stress, inflammation and apoptosis. 
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Introduction 
Phosphatidylethanolamine N-methyltransferase (Pemt) catalyzes the methylation of 
phosphatidylethanolamine (PE) to phosphatidylcholine (PC) as well as the conversion 
of S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH)[1]. The Pemt 
protein is localized in the endoplasmic reticulum (ER)-associated membranes in the 
liver. PC is mainly produced via the CDP-choline pathway, and is synthesized from 
diet-derived choline in liver tissue, while methionine is converted to SAM, which is the 
methyl donor for the conversion of PE catalyzed by Pemt. Pemt is responsible for the de 
novo synthesis of PC, accounting for ~30% of the PC in rodents[2]. The secretion of 
very low density lipoprotein (VLDL) from hepatocytes is facilitated by the enrichment 
of PC, and both CDP-choline and the Pemt pathways are required for the optimal 
secretion of VLDL from the liver[3]. Thus, Pemt-/- mice demonstrated decreased VLDL 
secretion, and Pemt deficiency strikingly protected Ldlr-/- mice from the development 
of atherosclerosis[4].  
Recently, Pemt has been shown to play a critical role in obesity and insulin 
resistance using Pemt-/- mice fed a high-fat diet. The Pemt-/- mice were protected from 
high-fat diet-induced weight gain and insulin resistance over the 10-week experimental 
period[5] and the deficiency in choline biosynthesis seems to provide the beneficial 
effects for glucose metabolism. Furthermore, the lipidomic analyses of the ER of the 
liver in obese mice revealed an increased PC/PE ratio, which was closely associated 
with inhibition of the sarco/endoplasmic reticulum calcium ATPase (SERCA) activities 
and the induction of ER stress in mice. The reduction of Pemt expression by short 
hairpin RNA (shRNA) led to the reduction of the PC/PE ratio and beneficial effects on 
ER stress and improved the glucose metabolism and fatty liver in mice[6]. 
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  The increased expression of Pemt in the liver under the obese state is linked to the 
overproduction of SAH, which is metabolized to homocysteine, thus resulting in 
increased serum levels of homocysteine. A higher serum homocysteine level is a 
well-known risk factor for cardiovascular disease[7,8] and progressive kidney 
disease[9,10]. Increased homocysteine levels are reported to cause both ER stress and 
local oxidative stress, which subsequently leads to the induction of glomerular cell 
dysfunction and glomerulosclerosis[11]. Although decrease the homocysteine level with 
folic acid and B vitamins did not reduce the risk for major cardiovascular events in 
patients with vascular diseases[8] or acute myocardial infarction[7], the inhibition of 
intrinsic Pemt activity may be beneficial by directly ameliorating the ER stress and 
oxidative stress, in addition to the homocysteine lowering effects. 
The Pemt mRNA and activity are predominantly expressed in the liver. However, 
low activity of Pemt has also been demonstrated in other tissues, such as the heart, 
kidneys and adipose tissues[1]. In diabetic nephropathy, proteinuria and hyperglycemia 
induce ER stress[12,13] and lead to subsequent oxidative stress[14], inflammatory 
responses[15] and apoptosis[16,17] in renal tubular cells, which ultimately progress to 
the end-stage renal disease associated with tubulointerstitial fibrosis. Since the Pemt 
expression has been shown to increase in streptozotocin (STZ)-induced diabetic rats[18], 
we hypothesized that a deficiency of Pemt may protect against the renal injuries 
associated with diabetic nephropathy by reducing the serum homocysteine levels or by 
directly ameliorating the ER stress in the kidney. In the present study, we generated 
Pemt knockout mice and demonstrated that the deficiency of Pemt protects against 
diabetic nephropathy by ameliorating the ER stress and subsequent pathways, such as 
those involving oxidative stress, inflammation and apoptosis. 
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Materials and Methods 
Generation of Pemt (phosphatidylethanolamine N-methyltransferase) knockout mice. 
The Pemt targeting vector was designed to replace exon 2 of Pemt with a 
PGK-neomycin resistance cassette. The 2.9 kb short (12081-15030) and 6.2 kb long arm 
(15440-21643) genomic DNA fragments (Figure S1 in File S1) were obtained from the 
C57BL/6 mouse Bac genomic clones (ID: RP23-101K22 and RP23-151K5, Roswell 
Park Cancer Institute) or the C57BL/6-derived ES genome by PCR using primers 
containing additional restriction enzyme recognition sites for subcloning; SacII and NotI 
for the short arm and ClaI and SalI for the long arm. The SacII-NotI-digested short arm 
PCR fragment was subcloned into the pBS-pA-loxp-NEO-SH vector (Unitech, Chiba, 
Japan). The targeting vector was constructed by subcloning the SacII-ClaI-digested 
short arm flanked by SV40 poly A-loxp-NEO-loxp, and the ClaI-SalI-digested long arm 
was subcloned into the pBS-NEO-DTA vector (Unitech, Chiba, Japan) constructed from 
pBlueScriptII SK+ (Stratagene, La Jolla, CA). The targeting plasmid was linearized 
by SacII digestion, and was electroporated into C57BL/6-derived embryonic stem (ES) 
cells. The homologous recombination of C57BL/6 ES cell clones was screened by a 
Southern blot analysis using a 5’-probe, NEO-probe and 3’-probe and EcoRI-digested 
genomic DNA. Chimeric mice were generated by injecting the targeted ES clone into 
C57BL/6 blastocysts. Male chimeric mice were mated with C57BL/6JJcl mice to 
generate heterozygous Pemt+/- mice, which were backcrossed to C57BL/6JJcl mice for 
more than five generations. The genotyping of Pemt-/- mice was performed by PCR 
using 5’-ATGAGACTTAAGTGCAGTGACTGTG-3’ and   
5’-CTTCCTCGTGCTTTACGGTATC-3’ as the primers, and Pemt+/+ mice were 
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identified by the 5’-ATGAGACTTAAGTGCAGTGACTGTG-3’ and  
5’- GGTACTCACCACATTCCAGAAGAGT -3’ sequences. 
 
Animals. Male Pemt-/- and Pemt+/+ mice were housed in cages and maintained on a 
12-hour light-dark cycle and received normal chow (MF, Oriental Yeast, Co., Ltd). 
Eight-week-old mice received five consecutive intravenous injections of 50 mg/kg 
streptozotocin (STZ) (Sigma, St. Louis, MO) in citrate buffer at pH 4.6 or citrate buffer 
only (as a control). A blood glucose level over 300 mg/dl was confirmed three days after 
the STZ administration at two different time points. We sacrificed the mice at 25 weeks 
of age and subjected them to the subsequent studies. All animal experiments were 
approved by the Animal Care and Use Committee of the Department of Animal 
Resources, Advanced Science Research Center, Okayama University.  
The serum total homocysteine levels were measured by an enzymatic 
colorimetric assay (Alfresa Co., Tokyo), the quantification of PC and PE was performed 
by thin-layer chromatography (TORAY Research Center, Tokyo) and the urinary 
albumin levels were measured using goat-antiserum against mouse albumin (Cappel) 
and a turbidimetric immunoassay in the BN II System (Siemens, Eschborn, Germany) 
and were normalized against the creatinine levels. 
 
Poly (A
+
) RNA analysis. For the quantitative real time PCR analysis, cDNAs 
synthesized from 2 μg of total RNA were amplified in the presence of primers and 
TaqMan Minor Groove Binder Probes (TaqMan Gene Expression Assays; Applied 
Biosystems, Carlsbad, CA) using a StepOnePlus Real Time PCR System. The relative 
abundance of Pemt mRNA (Mm00839436_m1, Applied Biosystems) was standardized 
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using β-actin mRNA (Mm00607939_s1) as the internal control. 
  
Cell culture. Mouse proximal tubular cells (mProx24) were cultured in DMEM with 5% 
FCS and 100 U/ml penicillin, 100 μg/ml streptomycin and 2 μM L-glutamine[19]. For 
the knockdown experiments, the mProx24 cells were transfected with 5 MOI 
(multiplicity of infection) of MISSION shRNA lentivirus transduction particles for 
Pemt (NM_008819) (shRNA-Pemt) or Non-Target shRNA control lentivirus 
transduction particles (shRNA-CON). Each group of shRNA-Pemt and shRNA-CON 
was divided into six sub-groups; normal glucose (NG), high glucose (HG), osmotic 
control for mannitol (Mn), DMSO, tunicamycin-treated and thapsigargin-treated groups.  
Tunicamycin and thapsigargin were purchased from SIGMA, and the stock solution was 
prepared in DMSO for the induction of ER stress. Prior to the high glucose stimulus and 
induction of ER stress, the cells were serum-starved in DMEM with 1% FCS for 24 
hours, then the culture media were changed to DMEM containing 1% FCS with NG 
(5.5 mM glucose), HG (25 mM glucose), Mn (5.5 mM glucose and 19.5 mM mannitol), 
1 μg/ml tunicamycin, 1 μM thapsigargin and 0.1% DMSO. After a 24-hour incubation, 
they were subjected to a Western blot analysis and CellTiter 96 Aqueous One Solution 
Cell Proliferation Assay (Promega, Madison, WI). All culture experiments were 
performed in triplicate. 
 
Western blot analyses. Kidney cortex tissues were excised and homogenized with lysis 
buffer (20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 10 mM benzamidine-HCL, 10 mM 
ε-amino-n-caproic acid, 2 mM phenylmethylsulfonyl fluoride and 1% Triton X-100). 
After centrifugation at 14,000 rpm for 30 min at 4
o
C, supernatants were collected for the 
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further analyses. Equal amounts of protein were subjected to SDS-PAGE under 
reducing conditions, and were electroblotted onto Hybond P polyvinylidine fluoride 
membranes (GE Healthcare Life Sciences, Pittsburg, PA). The membrane blots were 
immersed in a blocking solution containing 5% nonfat dry milk and Tris-buffered saline 
with Tween-20 (0.05% Tween-20, 20 mM Tris-HCl, and 150 mM NaCl, pH 7.6). Then, 
the membranes were incubated with the following primary antibodies: rabbit polyclonal 
anti-phospho-elF2α (Ser51), rabbit polyclonal anti-eIF2α, rabbit monoclonal anti-IRE1α 
(14C10), rabbit monoclonal anti-GAPDH (14C10), anti-phospho-Akt (Ser473), Akt, 
Caspase-3, Caspase-7 (Cell Signaling Technology, Beverly, MA), rabbit polyclonal to 
IRE1 (phospho S724), ATF6, XBP-1 (abcam, Cambridge, MA), goat polyclonal 
anti-GRP78 (C-20), rabbit polyclonal anti-p21(H-164), p27(C-19), cyclin D1(M-20) 
(Santa Cruz Biotechnology, Dallas, TX) and anti-PEMT antibody (abcam; ab172388). 
They were then incubated with anti-rabbit or anti-goat IgG conjugated with horseradish 
peroxidase (GE Healthcare Life Sciences). The blots were washed three times with 
Tris-buffered saline with Tween-20, immersed in ECL Plus Western Blotting Detection 
Reagents (GE Healthcare Life Sciences), and then the chemiluminescence was analyzed 
using the LAS-3000 mini instrument (FUJIFILM, Tokyo, Japan). 
 
Morphological studies. Renal tissue specimens were fixed in 10% formaldehyde and 
embedded in paraffin, and 4 μm-thick sections were prepared. The sections were stained 
with periodic acid-Schiff (PAS) and Masson-Trichrome. To evaluate the glomerular 
size, we examined 15 randomly selected glomeruli per animal at 16 weeks after the 
induction of diabetes. The area of the glomerular tuft and the mesangial matrix index 
(MMI) were measured using the Lumina Vision software program (Mitani Corporation, 
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Tokyo, Japan). The MMI was defined as the PAS-positive area in the tuft area, 
calculated using the following formula: MMI = (PAS positive area)/(tuft area). The 
results are expressed as the means ± SE. Immunofluorescence staining was performed 
using Collagen Type IV (C-19) and TGF-β1/2/3 (H-112) (Santa Cruz Biotechnology), 
and the type IV collagen expression was quantified using the Lumina Vision software 
program. Four μm-thick sections of formalin-fixed, paraffin-embedded tissues were 
deparaffinized and rehydrated, and sections were pretreated by microwaving them for 
10 minutes in Target Retrieval Solution (DAKO) for antigen retrieval. Nonspecific 
binding was blocked by incubation for 30 min in 10% goat or rabbit serum, as 
appropriate. The tissues were then incubated with a rat monoclonal anti-F4/80 antibody 
[CI:A3-1] (abcam), anti-PEMT antibody (abcam; ab172388) or BiP (C50B12) rabbit 
monoclonal antibody (Cell signaling Technologies) at 4
o
C overnight. After being 
washed in PBS, the sections were incubated with a biotinylated secondary antibody, the 
VECTASTAIN ABC Standard Kit (Vector Laboratories, Burlingame, CA). 
Immunochemical staining was performed with the ImmPACT DAB SUBSTRATE 
(Vector Laboratories, Burlingame, CA). 
 
Oxidant fluorescence microtopography. The intracellular generation of O
2-
 was 
assessed using hydroethidine. O
2-
 reacts with hydroethidine to produce ethidium 
bromide, which binds to nuclear DNA and gives red fluorescence. Unfixed frozen 
kidneys were cut into 30 μm-thick sections and placed on a glass slide. Hydroethidine 
(2x10
-6
 M in PBS) was applied to each tissue section. Slides were incubated in a 
light-protected and humidified chamber at 37
 o
C for 30 minutes. Images were obtained 
with a fluorescence microscope (BZ-8100, KEYENCE, Osaka). All tissue specimens 
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were processed and imaged in parallel. 
 
Statistical analysis. The data are expressed as the means ± s.e.m., and the multiple 
comparisons were performed by a one-way ANOVA with Bonferroni and Tukey 
corrections. A value of P < 0.05 was regarded as statistically significant. The data were 
analyzed using the IBM SPSS Statistics software program (IBM, Armonk, NY). 
 
Results 
Pemt deficiency reduces albuminuria in STZ-induced diabetic mice. To explore the 
role of Pemt in the progression of diabetic nephropathy, Pemt-/- mice were generated by 
a standard gene targeting method (Figure S1 in File S1). The Pemt-/- mice did not 
exhibit any abnormalities in their general appearance, and all animals fed normal chow 
were healthy until 48 weeks of age. In the Pemt+/+ mice, Pemt mRNA was 
predominantly expressed in the liver, but was also detected in the kidneys, brain, heart, 
skeletal muscle and adipose tissues (Figure 1a). Pemt protein was detected in the liver 
tissues, and was barely detected in the kidney tissues of Pemt+/+ mice by a Western 
blot analysis (Figure 1b). However, in the histochemical examinations, 
immunoreactivity for Pemt was demonstrated mainly in the cytoplasm of the tubular 
cells and also in the glomerular cells in STZ-induced diabetic Pemt+/+ mice (Figure 
1c), while no such staining was detected in control Pemt+/+ and Pemt-/- mice (Figures 
1d-f).  
After the induction of diabetes by STZ, mice were sacrificed at 25 weeks of 
age. The blood glucose levels were similar in both STZ-induced diabetic Pemt+/+ and 
Pemt-/- mice. The kidney/body weight ratios of the diabetic Pemt-/- mice tended to be 
11 
 
reduced compared with those of Pemt+/+ mice; however, the difference did not reach 
statistical significance (Figures 2a-d). Osmotic diuresis was observed in both Pemt+/+ 
and Pemt-/- diabetic mice, but the albuminuria was significantly suppressed in diabetic 
Pemt-/- mice compared with Pemt+/+ mice (0.31±0.05 v.s. 0.52±0.06 mg/gCr, p=0.007) 
(Figures 2e and f).  
Pemt converts S-adenosylmethionine (SAM) to S-adenosylhomocysteine 
(SAH), and SAH is metabolized to homocysteine, which is coupled with the conversion 
from PE to PC. The measurement of the serum homocysteine levels demonstrated that 
they were significantly reduced in diabetic Pemt-/- mice compared with Pemt+/+ mice 
(2.50±0.52 v.s. 4.47±0.18 μmol/l, p=0.035) (Figure 2g). In contrast, the PC/PE ratio 
was increased in Pemt-/- mice treated with STZ, and the Pemt deficiency did not reduce 
the PC/PE ratio in the diabetic Pemt-/- mice (Figure 2h). 
 
Pemt deficiency ameliorates glomerular hypertrophy, oxidative stress, inflammation 
and the accumulation of extracellular matrix in STZ-induced diabetic mice. The 
glomerular hypertrophy was significantly reduced in STZ-induced diabetic Pemt-/- mice 
compared with Pemt+/+ mice (4367±141 v.s. 5293±186 μm2, p=0.003) (Figures 3a-d 
and 3m). The mesangial matrix index and accumulation of intraglomerular type IV 
collagen was also significantly reduced in STZ-induced diabetic Pemt-/- mice compared 
with Pemt+/+ mice (Figures 3e, f, n and o). The kidneys from the STZ-treated 
Pemt+/+ mice demonstrated prominent increases in hydroethidine fluorescence 
compared with those from control Pemt+/+ mice; Pemt deficiency markedly reduced 
the renal cell-derived superoxide (Figure S2 in File S1). The immunoreactivity for 
transforming growth factor-β (TGF-β) in the glomeruli was also reduced in the diabetic 
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Pemt-/- mice (Figures 3i-l).  
     We further investigated the accumulation of F4/80 cells in the glomeruli, and the 
interstitial macrophage infiltration was significantly reduced in STZ-induced diabetic 
Pemt-/- mice compared with Pemt+/+ mice (Figures S3 and S4 in File S1). In addition 
to the amelioration of the pathological changes of glomeruli, Pemt deficiency also 
reduced the interstitial pathological alterations such as tubular atrophy, tubular dilatation 
and interstitial fibrosis (Figure 4). 
 
Pemt deficiency ameliorates endoplasmic reticulum stress in diabetic nephropathy. 
Pemt catalyzes the conversion of phosphathidylethanolamine to phosphatidylcholine, 
which is coupled with the conversion of SAM to SAH. It has been reported that 
diet-induced obesity increased the expression of Pemt and the PC/PE ratio in the liver, 
which impaired the ER homeostasis and induced ER stress. We therefore further 
evaluated the ER stress markers in the kidney tissues and cultured mouse proximal 
tubular cells (mProx24). We first investigated the localization and expression of a 
representative ER stress marker, 78 kDa glucose-regulated protein (GRP78). The 
immunoreactivity for GRP78 was widely distributed in the cytoplasm of tubular cells in 
both non-diabetic Pemt+/+ mice and Pemt-/- mice, and it was upregulated in 
STZ-treated Pemt+/+ mice (Figures 5a, c and d).  Pemt deficiency suppressed the 
upregulation of GRP78 in the tubular cells (Figure 5b). In glomerular cells, the 
expression of GRP78 was also enhanced by the induction of diabetes in both Pemt+/+ 
and Pemt-/- mice (Figures 5e-h). Although the size of the glomeruli was small, the 
expression of GRP78 was readily recognized in Pemt-/- mice, and there was no clear 
downregulation of GRP78 in the glomeruli.  
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To quantify the levels of ER-stress markers, we next performed a Western blot 
analysis. The upregulation of ATF6 and GRP78 in Pemt+/+ diabetic mice was 
significantly reduced in Pemt-/- diabetic mice (Figure 6 and Figure S5 in File S1). The 
induction of p-eIF2α, p-IRE1α and XBP-1 by STZ treatment was ameliorated by the 
Pemt deficiency; however, the difference did not reach statistical significance (Figure 6 
and Figure S5 in File S1).  
We next investigated cultured mProx24 cells treated with shRNA-CON (control) 
and shRNA-Pemt (Figure S6 in File S1). In the cultured mProx24 renal tubule cells, the 
treatment with a high glucose level did not alter the expression of Pemt or various ER 
stress markers, such as IRE1α, eIF2α, ATF6, XBP-1 and GRP78. In contrast, treatment 
with tunicamycin and thapsigargin enhanced the expression of GRP78 and the 
phosphorylation of IRE1α and elF2α. The treatment with shRNA-Pemt led to a ~30% 
reduction of Pemt, and it significantly suppressed the upregulation of GRP78 induced 
by tunicamycin and thapsigargin treatment. However, shRNA-Pemt did not suppress the 
ER stress-induced phosphorylation of IRE1α and elF2α (Figure S6 in File S1).  
 
Pemt deficiency ameliorates apoptosis under endoplasmic reticulum (ER) stress.  
Pemt is known to downregulate the PI3K/Akt pathway and induce apoptosis in liver 
cells[20]. In addition, hyperglycemia and oxidative stress upregulate the PI3K/Akt 
pathway, which is associated with early phase hyperplasia and apoptosis in the proximal 
tubular cells[21]. We next investigated the status of cell proliferation and apoptosis of 
tubular cells under ER stress. In the cultured mProx24 cells, the treatment with high 
glucose media did not alter the expression of cyclin D1, p21
Cip1
, p27
Kip1 
or p-Akt 
(Figures S7 and S8 in File S1). In contrast, the treatment with tunicamycin and 
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thapsigargin upregulated the expression of cyclinD1, downregulated p27
Kip1
 and p-Akt 
and inhibited the cell proliferation. Under ER stress induced by tunicamycin or 
thapsigargin, the treatment with shRNA-Pemt upregulated the level of p-Akt; however, 
it did not alter the proliferation of mProx24 cells.  
     We next evaluated the status of apoptosis in tubular cells. In the diabetic kidney, 
the number of TUNEL-positive apoptotic tubular cells was significantly reduced in 
Pemt-/- mice compared with Pemt+/+ mice (Figure 7). In cultured mProx24 cells, the 
treatment with tunicamycin or thapsigargin increased the levels of cleaved caspases 3 
and 7, and shRNA-Pemt also reduced the cleavage of caspases 3 and 7 compared with 
shRNA-CON (Figure S9 in File S1).  
 
Discussion 
ER stress is induced by the accumulation of de novo synthesized unfolded proteins, 
which activate the unfolded protein response (UPR). The three major arms of the UPR 
include the PKR-like eukaryotic initiation factor 2α kinase (PERK), inositol requiring 
enzyme 1 (IRE1α) and activating transcription factor-6 (ATF6) pathways. Upon 
accumulation of misfolded proteins in the ER or depletion of ER calcium stores, ATF6 
is released from GRP78 and cleaved by site-1 and site-2 proteases. Then, the fragments 
migrate to the nucleus and activate ER chaperones and enzymes that promote protein 
folding and the ER-associated degradation (ERAD). IRE1α becomes 
autophosphorylated and splices X-box binding protein 1 (XBP1) mRNA to yield a 
potent transcriptional activator. During the UPR, PERK phosphorylates eIF2α and the 
process reduces the initiation AUG codon recognition and the general rate of translation 
is reduced[22]. Although the induction of the UPR allows cells to recover from stress, 
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prolonged ER stress may be cytotoxic and lead to apoptosis[23]. The major 
proapoptotic effector molecules associated with prolonger ER stress are ATF4-mediated 
induction of C/EBP homologous protein-10 (CHOP/GADD153) and c-Jun N-terminal 
kinase (JNK)[23]. ATF4 and JNK are preferentially transcribed by the activation of 
eIF2α and IRE1α, respectively[12]. In addition, the canonical UPR is linked to 
additional cellular insults, including inflammatory and stress signal systems such as 
NFκB (nuclear factor κB)-IκB kinase (IKK) and the oxidative stress responses[15].  
A number of groups demonstrated upregulation of the ER stress response in diabetic 
nephropathy in an animal model of diabetes[12]. In STZ-treated rats, increased 
expression of GRP78 in both tubular and glomerular cells enhanced the expression of 
CHOP, JNK and caspase-12, and prominent kidney cell apoptosis was demonstrated[24]. 
In addition, the microarray data from biopsy samples of cases with established diabetic 
nephropathy revealed higher expression of GRP78, oxygen-regulated protein150 
(ORP150/HYOU1) and XBP-1 compared with the cases of mild diabetes[13]. In 
addition to these observational studies, functional experiments using gene targeting in 
mice demonstrated the important roles of GRP78 in the progression of renal disease. 
The knock-in mice that expressed a mutant GRP78, in which the retrieval sequence to 
the ER was deleted, showed significant tubulointerstitial lesions with aging and chronic 
protein overload[25]. GRP78 serves as a master regulator of the UPR sensors, ATF6, 
IRE1α, as well as PERK, and plays an important role in the progression of diabetic 
nephropathy.  
   The deficiency of Pemt in the liver reversed the increased ER PC/PE ratio, relieved 
ER stress and improved the systemic glucose homeostasis in a previous study of obese 
animals[6]. In the liver, the reduction of the PC/PE ratio by Pemt deficiency causes the 
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inhibition of SERCA activity, which results in an amelioration of ER stress[6]. However, 
in the kidney tissues, we did not observe any significant reduction of PC/PE ratio in the 
Pemt -/- mice treated with STZ. Therefore, alternative mechanisms may operate to 
reduce the ER stress in different tissues. The reduction of the homocysteine levels by 
Pemt deficiency in our investigation may be linked to the amelioration of ER stress, 
since homocysteine has been reported as an inducer of ER stress through the depletion 
of Ca
2+
 in the ER[26]. In STZ-induced diabetic mice, the glucose metabolism was not 
altered by Pemt deficiency. However, the ER stress in the kidney tissues was 
ameliorated and the expression of GRP78 was reduced. In the current investigation, we 
demonstrated that the amelioration of ER stress by Pemt deficiency corrected the three 
major consequences of ER stress; oxidative stress[14], the inflammatory responses[15] 
and apoptosis[16,17].  
The alterations in the oxidative environment of the ER and the calcium 
concentration in the ER cause the production of ER stress-induced reactive oxygen 
species. For a protein to fold into the correct conformation in the ER, the formation of 
intramolecular and intermolecular disulfide bonds is required[27]. Electron transport 
during the disulfide bond formation is driven by a protein relay involving ER-resident 
enzymes; protein disulfide isomerase (PDI) and ER oxidoreductin 1 (ERO1)[28]. 
Although it provides a robust driving force for disulfide bond formation, the 
consumption of oxygen for the terminal electron leads to the production of ROS[15]. 
Furthermore, the mitochondria contribute to lethal levels of ROS during the sustained 
ER stress by affecting the mitochondrial electron transfer system[14]. Hyperglycemia 
also contributes to the ROS production from mitochondria by enhancing the supply and 
influx of pyruvate and generating high electrochemical potential[29]. The production of 
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ROS is tightly linked to the inflammatory responses, and promotes the activation of 
caspase-3 and caspase-12, and also induces tubular apoptosis[30].  
ER stress induces the activation of transcription factor such as nuclear factor-κB and 
JNK, and stimulates the inflammatory responses[15]. The amelioration of ER stress by 
Pemt deficiency inhibited the intraglomerular macrophage infiltration, the accumulation 
of extracellular matrix and subsequent tubulointerstitial fibrosis. Microinflammation 
and subsequent extracellular matrix expansion are common pathways for the 
progression of diabetic nephropathy. In recent years, many researchers have 
demonstrated that the inflammation pathways play central roles in the progression of 
diabetic nephropathy, and the identification of the inflammatory molecules involved in 
this process may lead to the development of new therapeutic strategies[31]. The 
molecules related to the inflammation pathways in diabetic nephropathy include 
transcription factors, proinflammatory cytokines, chemokines, adhesion molecules, 
Toll-like receptors, adipokines and nuclear receptors, which are candidate molecular 
targets for the treatment of diabetic nephropathy[31]. The inhibition of Pemt and 
amelioration of ER stress is an emerging target for treating the microinflammation in 
diabetic nephropathy. 
   During the process of ER stress, ROS, caspase-3, caspase-12[30], and mammalian 
target of rapamycin (mTOR)[32] promote the induction of apoptosis. In contrast, the 
downregulation of Akt signaling[21] and knock-out of CHOP in mice[17] were 
demonstrated to facilitate the process of ER-induced apoptosis. In the case of diabetic 
nephropathy, long-term hyperglycemia downregulates the Akt activation and contributes 
to enhanced p38 mitogen-activated protein kinase (MAPK) activation and the apoptosis 
of renal tubular cells[21]. In our study, we observed that Pemt deficiency relieved the 
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ER stress, activated the phosphorylation of Akt and prominently reduced the apoptosis 
of proximal tubular cells. The relationship between Pemt and Akt signaling was already 
reported in hepatocytes, where the overexpression of Pemt downregulated the PI3K/Akt 
signaling[20]. 
  Taken together, the inhibition of Pemt activity appears to ameliorate the ER stress 
associated with diabetic nephropathy, and to correct the subsequent three major 
pathways downstream of ER stress, i.e. oxidative stress, inflammation and apoptosis. 
During the search for small molecules that upregulate GRP78 expression, GRP78 
inducers such as trans-4,5-dihydroxy-1,2-dithiane (DTTox) and BiP inducer X (BIX) 
were identified[33]. In addition, extensive efforts were made to identify chemical 
chaperones. These studies demonstrated that 4-phenylbutyrate (4-PBA) improves the 
ER folding capacity and facilitates the trafficking of unfolded proteins, and the 
endogenous bile acid derivatives, such as tauroursodeoxycholic acid (TUDCA), also 
protect cells against ER stress-induced apoptosis[34]. The current study suggests that 
the identification of small molecules which inhibit the Pemt activity may be useful in 
the amelioration of ER stress and ER stress-induced apoptosis in diabetic nephropathy. 
In addition to our findings, Pemt inhibition has been previously reported to have 
therapeutic potential for insulin resistance and obesity, and also for the prevention of 
atherosclerosis[4,6]. Therefore, Pemt inhibitors may be useful in the treatment of 
diabetic nephropathy in patients with type 1 diabetes, as well as for other ER stress- and 
oxidative stress-related diseases. 
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Figure legends 
Figure 1. The mRNA and protein expression of phosphatidylethanolamine 
N-methyltransferase (Pemt). a. The results of the quantitative RT-PCR assay for Pemt 
mRNA in various tissues of C57BL/6JJcl mice (n=4).  b. The Western blot analysis of 
Pemt in the kidney and liver tissues of Pemt+/+ mice and Pemt-/- C57BL/6JJcl mice.  
c-f. Immunoperoxidase staining for Pemt in the kidney tissue of Pemt+/+ mice and 
Pemt-/- mice. Immunoreactivity was seen in the proximal tubules and glomerular cells 
in streptozotocin (STZ)-treated Pemt+/+ mice (c), but not in control Pemt+/+ mice (e) 
or Pemt-/- mice (d and f). Bars = 50 μm (c-f). 
 
Figure 2. The metabolic data and findings of albuminuria in streptozotocin 
(STZ)-treated diabetic Pemt+/+ and Pemt -/- C57BL/6JJcl mice. The Pemt+/+ and 
Pemt -/- mice were treated with citrate buffer (CON) or streptozotocin (STZ). a. Body 
weight (g), b. kidney weight (g), c. kidney/body weight, d. blood glucose levels (mg/dl), 
e. urine volume (ml/day), f. albumin level (mg/gCr) and g. serum homocysteine level 
(μmol/l). The daily albumin excretion and serum homocysteine levels were significantly 
reduced in Pemt-/- (STZ) mice compared with Pemt+/+ (STZ) mice. h. The 
phosphatidylethanolamine (PE) and phosphatidylcholine (PC) contents were measured 
in the kidney tissues by thin-layer chromatography. The PC/PE ratio was significantly 
increased in Pemt-/- (STZ) compared with Pemt-/- (CON) mice; however, there was no 
statistically significant difference between the Pemt-/- (STZ) and Pemt+/+ (STZ) mice.  
##
P < 0.01 v.s. Pemt+/+ (CON). **P < 0.01, *P < 0.05 v.s. Pemt+/+ (STZ).  
 
Figure 3. The results of the histochemical and morphometric analyses of streptozotocin 
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(STZ)-treated diabetic Pemt+/+ and Pemt -/- C57BL/6JJcl mice. The Pemt+/+ and 
Pemt -/- mice were treated with citrate buffer (CON) or streptozotocin (STZ). a-d. 
Periodic acid-Schiff stain, e-h. immunofluorescence staining for type IV collagen, i-l. 
immunofluorescence staining for TGF-β, m. the glomerular area (μm2), n. the mesangial 
matrix index (%) and o. the type IV collagen positive area/glomerular area (%). The 
glomerular hypertrophy, mesangial area and type IV collagen positive area were 
significantly reduced in Pemt-/- (STZ) mice compared with Pemt+/+ (STZ) mice. Bars 
= 50 μm (a-l). ##P < 0.01, #P < 0.05 v.s. Pemt+/+ (CON). **P < 0.01, *P < 0.05 v.s. 
Pemt+/+ (STZ). 
 
Figure 4. The tubulointerstitial injuries in streptozotocin (STZ)-treated diabetic 
Pemt+/+ and Pemt -/- C57BL/6JJcl mice. The Pemt+/+ and Pemt -/- mice were treated 
with citrate buffer (CON) or streptozotocin (STZ). a-d. Periodic acid-Schiff stain. The 
tubular atrophy, dilatation and interstitial fibrosis were ameliorated in Pemt-/- (STZ) 
mice compared with Pemt+/+ (STZ) mice. Bars = 300 μm (a-d). e. Fibrosis area 
(%).
##
P < 0.01 v.s. Pemt+/+ (CON). **P < 0.01 v.s. Pemt+/+ (STZ). 
 
Figure 5. The expression of 78 kDa glucose-regulated protein (GRP78) in 
streptozotocin (STZ)-treated diabetic Pemt+/+ and Pemt -/- C57BL/6JJcl mice. The 
Pemt+/+ and Pemt -/- mice were treated with citrate buffer (CON) or streptozotocin 
(STZ). a-d. Immunoperoxidase staining for GRP78 (Bars = 300 μm), e-h. 
Immunoperoxidase staining for GRP78 (Bars = 100 μm). The immunoreactivity for 
GRP78 was widely distributed in the cytoplasm of tubular cells in both non-diabetic 
Pemt+/+ mice and Pemt-/- mice, and was upregulated in STZ-treated Pemt+/+ mice.  
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Figure 6. The results of the Western blot analyses of the renal cortex tissues from 
Pemt+/+ and Pemt -/- mice treated with citrate buffer (CON) or streptozotocin (STZ). 
The upregulation of ATF6 and GRP78 in Pemt+/+ diabetic mice was reduced in Pemt-/- 
diabetic mice. The induction of p-eIF2α, p-IRE1α and XBP-1 by STZ treatment was 
ameliorated by the Pemt deficiency; however the difference between the groups did not 
reach statistical significance (Supplemental Figure 5). 
 
Figure 7. Apoptosis in the streptozotocin (STZ)-treated diabetic Pemt+/+ and Pemt -/- 
C57BL/6JJcl mice and in mProx24 cells treated with MISSION shRNA lentivirus 
transduction particles for Pemt (shRNA-Pemt) and Non-Target shRNA control lentivirus 
transduction particles (shRNA-CON). a. and b. The results of the in situ TUNEL assay 
in Pemt-/- (STZ) and Pemt+/+ (STZ) mice. Bars = 100 μm. c. The quantification of 
apoptotic cells in the kidney cortex. The number of TUNEL-positive cells was 
significantly reduced in the Pemt-/- (STZ) mice compared with Pemt+/+ (STZ) mice. 
#
P < 0.05; STZ-treated group (STZ) v.s. citrate buffer treated control group (CON). *P < 
0.05; Pemt+/+ (STZ) v.s. Pemt-/- (STZ). d. The results of the Western blot analyses of 
caspases 3 and 7 in the renal cortex tissues of Pemt+/+ and Pemt -/- mice. e. The 
increase in cleaved caspases 3 and 7 was ameliorated by the deficiency of Pemt in 
STZ-treated mice. 
##
P < 0.01, 
#
P < 0.05 v.s. Pemt+/+ (CON). **P < 0.01, *P < 0.05 v.s. 
Pemt+/+ (STZ). 
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Supporting Information Legends 
Figure S1 in File S1. A schematic diagram of the strategy used to disrupt the mouse 
Pemt gene. a. Schematic drawings of the Pemt targeting vector. b. The targeted 
recombination in ES cells (lines 135, 144, 152 and 162) was confirmed by the Southern 
blot analyses of genomic DNA digested with EcoRI, and the expected sizes of wild-type 
and Pemt gene-targeted bands using a 5’-probe, 3’-probe and NEO-probe are shown, 
respectively. 
 
Figure S2 in File S1. Oxidant fluorescence microtopography using hydroethidine in 
streptozotocin (STZ)-treated diabetic Pemt+/+ and Pemt -/- C57BL/6JJcl mice. The 
Pemt+/+ and Pemt -/- mice were treated with citrate buffer (CON) or STZ. a-d. The 
Pemt+/+ (STZ) mice demonstrated a prominent increase in hydroethidine fluorescence, 
and Pemt deficiency markedly reduced the renal cell-derived superoxide. Bars = 300 
μm (a-d). 
 
Figure S3 in File S1. The intraglomerular macrophage infiltration in streptozotocin 
(STZ)-treated diabetic Pemt+/+ and Pemt -/- C57BL/6JJcl mice. Pemt+/+ and Pemt -/- 
mice were treated with citrate buffer or STZ. a-d. Immunoperoxidase staining for F4/80, 
e. The number of F4/80 positive cells/glomerulus. The number of glomerular 
F4/80-positive cells was significantly reduced in Pemt-/- (STZ) mice compared with 
Pemt+/+ (STZ) mice. Bars = 20 μm (a-d). ##P < 0.01 v.s. Pemt+/+ (CON). **P < 0.01 
v.s. Pemt+/+ (STZ). 
 
Figure S4 in File S1. The interstitial macrophage infiltration in streptozotocin 
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(STZ)-treated diabetic Pemt+/+ and Pemt -/- C57BL/6JJcl mice. Pemt+/+ and Pemt -/- 
mice were treated with citrate buffer or STZ. a-d. Immunoperoxidase staining for F4/80, 
e. The number of F4/80 positive cells in the interstitium per mm
2
. The number of 
interstitial F4/80-positive cells was significantly reduced in Pemt-/- (STZ) mice 
compared with Pemt+/+ (STZ) mice. Bars = 50 μm (a-d). ##P < 0.01 v.s. Pemt+/+ 
(CON). **P < 0.01 v.s. Pemt+/+ (STZ). 
 
Figure S5 in File S1. The results of the densitometric analyses of the Western blots of 
renal cortex tissues from Pemt+/+ and Pemt -/- mice treated with citrate buffer or 
streptozotocin (STZ), which appeared in Figure 6. 
##
P < 0.01 v.s. Pemt+/+ (CON). **P 
< 0.01, *P < 0.05 v.s. Pemt+/+ (STZ). 
 
Figure S6 in File S1. Endoplasmic reticulum (ER) stress-related markers in mProx24 
cells treated with MISSION shRNA lentivirus transduction particles for Pemt 
(shRNA-Pemt) and Non-Target shRNA control lentivirus transduction particles 
(shRNA-CON). The mProx24 renal tubule cells were treated with normal glucose (NG), 
high glucose (HG), an osmotic control using mannitol (Mn), DMSO, tunicamycin or 
thapsigargin. **P < 0.01, *P < 0.05 v.s. shRNA-CON. 
 
Figure S7 in File S1. The expression levels of cyclin D1, p21
Cip1
, p27
Kip1
 and p-Akt in 
mProx24 cells treated with MISSION shRNA lentivirus transduction particles for Pemt 
(shRNA-Pemt) and Non-Target shRNA control lentivirus transduction particles 
(shRNA-CON). The mProx24 cells were treated with normal glucose (NG), high 
glucose (HG), an osmotic control using mannitol (Mn), DMSO, tunicamycin or 
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thapsigargin. The treatments with tunicamycin and thapsigargin upregulated cyclin D1 
and downregulated p27
Kip1
 and p-Akt. shRNA-Pemt led to prominent recovery and 
increased the expression of p-Akt. However, the anti-proliferative activities of 
tunicamycin and thapsigargin were not reversed by the treatment with shRNA-Pemt, as 
revealed by the CellTiter96 Aqueous One Solution Cell Proliferation Assay. 
 
Figure S8 in File S1. The results of the densitometric analyses of the Western blot 
analyses of the levels of cyclin D1, p21
Cip1
, p27
Kip1
 and p-Akt in mProx24 cells treated 
with MISSION shRNA lentivirus transduction particles for Pemt (shRNA-Pemt) and 
Non-Target shRNA control lentivirus transduction particles (shRNA-CON). **P < 0.01, 
*P < 0.05 v.s. shRNA-CON. 
 
Figure S9 in File S1. The densitometric analyses of the Western blots of caspases 3 and 
7 in mProx24 cells treated with MISSION shRNA lentivirus transduction particles for 
Pemt (shRNA-Pemt) and Non-Target shRNA control lentivirus transduction particles 
(shRNA-CON). The treatments with tunicamycin and thapsigargin increased the levels 
of cleaved caspases 3 and 7, while the treatment with shRNA-Pemt reduces the levels of 
cleaved caspases 3 and 7. **P < 0.01, *P < 0.05 v.s. shRNA-CON. 
 
